Skip to content
Back to recalls
Drug FDA Class I Terminated Foreign material

Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317

Staska Pharmaceuticals, Inc. Published Nov 13, 2024

Risk level

Class I

Dangerous or defective — could cause serious health problems or death.

Severity score 80/100

What should you do?

  • Check whether you have this product, using the lot codes, UPCs, and dates listed below.
  • Do not eat, serve, or sell the affected product.
  • Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
  • Contact Staska Pharmaceuticals, Inc. or your place of purchase with questions, and see the source record below for full details.
Reason for recall

Presence of Particulate Matter: Presence of glass particulates.

Hazards

Glass Particulate · primary

Affected products (1)

Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317

4773 vials

Lot codes: SP2400058
Code info: Lot #SP2400058, Exp 12/31/2024

Affected areas

Nationwide

Timeline

  1. Initiated
    Sep 30, 2024
  2. Published
    Nov 13, 2024
  3. Terminated
    Aug 5, 2025
Recall number
D-0040-2025
Agency
U.S. Food and Drug Administration
Country
US
Source data (openFDA JSON) About FDA enforcement reports

FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.